Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangdong, China.
Department of Child and Adolescent Psychiatry, Peking University Sixth Hospital (Institute of Mental Health), National Clinical Research Center for Mental Disorders and NHC Key Laboratory of Mental Health (Peking University Sixth Hospital), Beijing, China.
Adv Nutr. 2022 Dec 22;13(6):2217-2236. doi: 10.1093/advances/nmac084.
Unsaturated fatty acids might be involved in the prevention of and improvement in mental disorders, but the evidence on these associations has not been comprehensively assessed. This umbrella review aimed to appraise the credibility of published evidence evaluating the associations between unsaturated fatty acids and mental disorders. In this umbrella review, systematic reviews and meta-analyses of studies comparing unsaturated fatty acids (including supplementation, dietary intake, and blood concentrations) in participants with mental disorders with healthy individuals were included. We reanalyzed summary estimates, between-study heterogeneity, predictive intervals, publication bias, small-study effects, and excess significance bias for each meta-analysis. Ninety-five meta-analyses from 29 systematic reviews were included, encompassing 43 studies on supplementation interventions, 32 studies on dietary factors, and 20 studies on blood biomarkers. Suggestive evidence was only observed for dietary intake, in which higher intake of fish was associated with reduced risk of depression (RR: 0.78; 95% CI: 0.69, 0.89) and Alzheimer disease (RR: 0.74; 95% CI: 0.63, 0.87), and higher intake of total PUFAs might be associated with a lower risk of mild cognitive impairment (RR: 0.71; 95% CI: 0.61, 0.84). Evidence showed that PUFA supplementation was favorable but had weak credibility in anxiety, depression, attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), dementia, mild cognitive impairment, Huntington's disease, and schizophrenia (P-random effects <0.001-0.040). There was also weak evidence on the effect of decreased circulating n-3 (ɷ-3) PUFAs among patients on risk of ADHD, ASD, bipolar disorder, and schizophrenia (P-random effects <10-6-0.037). Our results suggest that higher levels of unsaturated fatty acids may relieve symptoms or reduce the risk of various mental disorders; however, the strength of the associations and credibility of the evidence were generally weak. Future high-quality research is needed to identify whether PUFA interventions should be prioritized to alleviate mental disorders.
不饱和脂肪酸可能与精神障碍的预防和改善有关,但这些关联的证据尚未得到全面评估。本 umbrella 综述旨在评估评估不饱和脂肪酸与精神障碍之间关联的已发表证据的可信度。在本 umbrella 综述中,纳入了比较精神障碍患者与健康个体之间不饱和脂肪酸(包括补充剂、饮食摄入和血液浓度)的系统评价和荟萃分析。我们重新分析了每个荟萃分析的汇总估计值、研究间异质性、预测区间、发表偏倚、小样本效应和过度显著性偏差。纳入了 29 项系统评价的 95 项荟萃分析,其中包括 43 项补充干预研究、32 项饮食因素研究和 20 项血液生物标志物研究。仅观察到饮食摄入方面的提示性证据,其中较高的鱼类摄入量与降低抑郁风险相关(RR:0.78;95%CI:0.69,0.89)和阿尔茨海默病(RR:0.74;95%CI:0.63,0.87),而总多不饱和脂肪酸(PUFA)的较高摄入量可能与轻度认知障碍的风险降低相关(RR:0.71;95%CI:0.61,0.84)。证据表明,PUFA 补充剂在焦虑、抑郁、注意缺陷/多动障碍(ADHD)、自闭症谱系障碍(ASD)、痴呆、轻度认知障碍、亨廷顿病和精神分裂症方面是有利的,但可信度较弱(P-随机效应<0.001-0.040)。在接受治疗的患者中,循环 n-3(ω-3)PUFA 水平降低与 ADHD、ASD、双相情感障碍和精神分裂症风险之间的关联也存在较弱的证据(P-随机效应<10-6-0.037)。我们的研究结果表明,较高水平的不饱和脂肪酸可能缓解各种精神障碍的症状或降低其风险;然而,关联的强度和证据的可信度普遍较弱。需要开展高质量的未来研究,以确定是否应优先考虑 PUFA 干预来缓解精神障碍。